Mylan N.V. has launched doxycycline hyclate delayed-release tablets (200 mg), an antibiotic, in the United States. Mylan said its doxycycline product is a generic version of Doryx 200-mg delayed-release tablets from Mayne Pharma.
The National Association of Chain Drug Stores Foundation this week plans to hold a webinar on protection against the Zika virus.
IM HealthScience (IMH) has launched FDgard, a nonprescription medical food for the dietary management of functional dyspepsia (FD), or persistent or recurring indigestion. IMH said Monday that FDgard is now available in the digestive aisle at most CVS/pharmacy and Walgreens stores nationwide.
A study funded by the National Association of Chain Drug Stores Foundation aims to boost testing for hepatitis C and connect patients to care. This week, the NACDS Foundation said its study is under way in 50 stores with pharmacies, and a total of 75 locations are planned in the greater Detroit,
The Food and Drug Administration is again postponing the release of a final rule that would change generic drug labeling requirements.
Amid calls for a quicker approval process, the Food and Drug Administration last year cleared for market the most generic drug products in its history. The FDA said it approved or issued tentative approvals for more than 700 generic drugs in 2015.
The National Community Pharmacists Association has joined with a group of pharmacy industry stakeholders in calling for more clarity about direct and indirect (DIR) fees.
Bristol-Myers Squibb has completed a major expansion of its biologics facility in Devens, Mass. The drug maker said the $280 million project will spur development of the company’s growing portfolio of biologics medicines.
Making changes to its Pharmaceuticals Division, Novartis has created two business units that will report to the chief executive officer: Novartis Pharmaceuticals and Novartis Oncology. The new units will form the Innovative Medicines Division.
McKesson Corp. and Walmart have expanded their long-term pharmaceutical distribution pact, including a new sourcing agreement for generic drugs. McKesson and Walmart said Monday that the expanded relationship is “a natural next step.” The companies will collaborate on sourcing generics for their U.
Mylan N.V. has entered an agreement to buy the nonsterile, topicals-focused specialty and generics business of Renaissance Acquisition Holdings LLC for $950 million in cash.
Smith Drug Co. is providing independent pharmacies access to specialty pharmacy services under a new partnership with Diplomat Pharmacy Inc.
Benzer Pharmacy has received specialty pharmacy accreditation from health standards body URAC. The drug chain said that the Benzer Pharmacy in Auburndale, Fla., has been granted full accreditation pursuant to Specialty Pharmacy, Version 2.1.
Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for oxymorphone HCl tablets 5 mg and 10 mg, an opioid painkiller. Aurobindo said Thursday that its oxymorphone tablet product is a generic version of Opana tablets (5 mg and 10 mg) from Endo Pharmaceuticals Inc.
QS/1 has become the first pharmacy management software vendor to be able to interface with SureMed by Omnicell Guided Packing software.
The National Association of Chain Drug Stores and the National Community Pharmacists Association have made some headway in their push to rein in pharmacy co-payments for TRICARE, the U.S. armed forces health benefits program.
